Using genes borrowed from bacteria, researchers have demonstrated fish and flies can be engineered to break down methylmercury and remove it from their bodies as a less harmful gas, offering new ways ...
The fourth Subject was safely treated with the low-dose of BB-301 in December 2024, and the fifth Subject was safely treated with the low-dose of BB-301 in early February 2025. The sixth Subject is ...
Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...
Imagine being summoned as a juror in a murder trial. The expert responsible for analyzing DNA traces at the crime scene has ...
National Coordinator, the Nigeria Reduced Emissions from Deforestation and Degradation (REDD ) Programme, Salisu Dahiru, has called on state governments in Nigeria to embrace... The African Union ...
They show that he plans to divest stock holdings, including stakes in biotech firms CRISPR Therapeutics AG and Dragonfly Therapeutics. He’s also stepping down from roles at his law firm and at ...
A requisite majority of H-class shareholders did not approve the buyout, the companies said. "The proposed privatisation of the Company (Henlius) will not proceed and the listing of the H Shares ...
Primarily, Ascentage hopes to leverage the IPO proceeds to advance its pipeline. Around $50 million to $60 million, for instance, will help the biotech pursue approval for its BCL-2 blocker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results